Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?"
Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?"
Date
2023
Authors
Matthews, Philippa C.
Ocama, Ponsiano
Wang, Su
El-Sayed, Manal
Turkova, Anna
Ford, Deborah
Torimiro, Judith
Ferreira, Ana Cristina Garcia
Espinosa Miranda, Angélica
De La Hoz Restrepo, Fernando Pio
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
In response to our article,1 Zhou and Zhao pose the question of whether interventions for prevention-of-mother-to-child-transmission (PMTCT) need to be enhanced. 2 As MTCT is now the major contributor to new cases of HBV infection, and approaching one million people die of this infection each year, the answer to this question is unequivocally yes – and with urgency. We tackle specific points raised by Zhou and Zhao in turn.
Description
Keywords
Maternal antiviral prophylaxis,
Mother-to-child transmission,
Hepatitis B virus
Citation
Matthews, P.C., et al. (2023). Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?".” JHEP Reports : Innovation in Hepatology, 5(11): 100875.